Medtronic Dividenden en inkoop

Dividend criteriumcontroles 5/6

Medtronic is een dividendbetalend bedrijf met een huidig rendement van 3.02% dat ruimschoots wordt gedekt door de winst.

Belangrijke informatie

3.0%

Dividendrendement

3.5%

Terugkoop Rendement

Totaal aandeelhoudersrendement	6.5%
Toekomstig dividendrendement	3.2%
Dividendgroei	8.3%
Volgende betaaldatum dividend	n/a
Ex-dividenddatum	n/a
Dividend per aandeel	US$2.800
Uitbetalingsratio	85%

Recente updates van dividend en inkoop

Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year

Jun 27

Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Jun 10

Recent updates

Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release

Feb 15

Medtronic: Undervalued But Underperforming - Why Innovation Isn't Enough To Lift The Stock

Feb 07

Medtronic (NYSE:MDT) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Dec 03

Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing

Nov 19

Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Nov 08

Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)

Oct 31

Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?

Oct 13

Medtronic: Undervalued Dividend Aristocrat With High Margins

Oct 10

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued

Sep 30

Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks

Sep 16

Medtronic: An Undervalued Stock With Durable Competitive Advantages

Sep 16

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Sep 05

Medtronic: Is The Company Back?

Aug 26

Medtronic: Still A Buy Before Earnings

Aug 17

Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down

Aug 08

Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential

Jul 16

At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?

Jul 11

Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year

Jun 27

Medtronic: Why I Disagree With The Crowd

Jun 14

Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Jun 10

Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued

May 27

Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70

May 26

These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

May 22

Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release

May 13

Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

May 01

35% Undervalued? Medtronic's Future Looks Very Bright

Apr 12

Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now

Mar 27

Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth

Mar 11

Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Mar 11

Medtronic: Its Recent Beat Proves That It Continues To Be A Rock

Feb 25

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 22

Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility

Feb 16

Medtronic Stock's Rally Is Set To Continue

Jan 11

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: Het dividend per aandeel van MDT is de afgelopen 10 jaar stabiel gebleven.

Groeiend dividend: De dividendbetalingen van MDT zijn de afgelopen 10 jaar gestegen.

Dividendrendement versus markt

Medtronic Dividendrendement versus markt

Hoe verhoudt MDT dividendrendement zich tot de markt?
Segment	Dividendrendement
Bedrijf (MDT)	3.0%
Markt onderkant 25% (US)	1.4%
Markt Top 25% (US)	4.4%
Gemiddelde industrie (Medical Equipment)	1.6%
Analist prognose (MDT) (tot 3 jaar)	3.2%

Opmerkelijk dividend: Het dividend van MDT ( 3.02% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de US markt ( 1.43% ).

Hoog dividend: Het dividend MDT ( 3.02% ) is laag vergeleken met de top 25% van dividendbetalers in de US markt ( 4.44% ).

Winstuitkering aan aandeelhouders

Verdiendekking: Bij de huidige payout ratio ( 84.7% ) worden de betalingen van MDT gedekt door de winst.

Contante uitbetaling aan aandeelhouders

Kasstroomdekking: Met zijn redelijke cash payout ratio ( 65.3% ) worden de dividendbetalingen van MDT gedekt door kasstromen.

Ontdek bedrijven met een sterk dividend

Bedrijfsanalyse en status van financiële gegevens

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2025/02/16 13:48
Aandelenkoers aan het einde van de dag	2025/02/14 00:00
Inkomsten	2024/10/25
Jaarlijkse inkomsten	2024/04/26

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

^* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Medtronic plc wordt gevolgd door 64 analisten. 28 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

Analist	Instelling
Kadambari Daptardar	Accountability Research Corporation
Harshit Gupta	Accountability Research Corporation
David Toung	Argus Research Company

Medtronic Dividenden en inkoop

Dividend criteriumcontroles 5/6

Belangrijke informatie

Recente updates van dividend en inkoop

Upcoming dividend of US$0.70 per share

Medtronic plc Announces Cash Dividend for Third Quarter of Fiscal Year 2025, Payable on January 10, 2025

Upcoming dividend of US$0.70 per share

Medtronic plc Announces Cash Dividend for Second Quarter of Fiscal Year 2025, Payable on October 11, 2024

Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year

Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Recent updates

Medtronic: Several Reasons For Optimism Before The Upcoming Earnings Release

Medtronic: Undervalued But Underperforming - Why Innovation Isn't Enough To Lift The Stock

Medtronic plc to Report Q2, 2026 Results on Nov 18, 2025

Medtronic plc to Report Q1, 2026 Results on Aug 19, 2025

Insider notifies of intention to sell stock

Now 20% undervalued after recent price drop

Medtronic plc Announces Chief Financial Officer Changes, Effective March 3, 2025

Medtronic plc Announces Chief Financial Officer Changes

We Think Medtronic (NYSE:MDT) Can Stay On Top Of Its Debt

Medtronic Announces CMS National Coverage Analysis for Symplicity™ Spyral Renal Denervation System

Medtronic: A Dividend Aristocrat That's Poised To Pop

Investors Appear Satisfied With Medtronic plc's (NYSE:MDT) Prospects

Medtronic Stock Is Still A Great "Buy"

Upcoming dividend of US$0.70 per share

Second quarter dividend of US$0.70 announced

Medtronic plc Announces Cash Dividend for Third Quarter of Fiscal Year 2025, Payable on January 10, 2025

Medtronic (NYSE:MDT) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Medtronic plc Receives FDA Clearance for New Inpen App, Pending the Way for Its Smart MDI System Launch with Simplera™? CGM

New minor risk - Earnings quality

Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing

Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

CMS Grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral Renal Denervation Catheter

Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)

Medtronic plc Announces New, Long-Term Data from Its SPYRAL HTN-ON MED Clinical Trial

Medtronic plc Receives FDA Approval of Affera Mapping and Ablation System and Sphere-9 Catheter

Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?

Medtronic: Undervalued Dividend Aristocrat With High Margins

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc Announces the Presentation of Clinical Study Results

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued

Upcoming dividend of US$0.70 per share

Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks

Medtronic: An Undervalued Stock With Durable Competitive Advantages

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Consensus EPS estimates increase by 12%

Medtronic: Is The Company Back?

First quarter 2025 earnings: EPS exceeds analyst expectations

Medtronic plc Revises Earnings Guidance for the Fiscal Year 2025

Fourth quarter dividend of US$0.70 announced

Medtronic: Still A Buy Before Earnings

Medtronic plc Announces Cash Dividend for Second Quarter of Fiscal Year 2025, Payable on October 11, 2024

Medtronic plc, Annual General Meeting, Oct 17, 2024

Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down

Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential

At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?

Now 25% undervalued after recent price drop

New minor risk - Earnings quality

Now 20% undervalued after recent price drop

Medtronic plc Announces Resignation of Karen Parkhill as CFO

Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year

Medtronic plc Announces Resignation of Karen Parkhill as CFO

Full year 2024 earnings: EPS misses analyst expectations

Medtronic: Why I Disagree With The Crowd

Chairman of the Board & CEO notifies of intention to sell stock

Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Medtronic plc Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024

Consensus EPS estimates fall by 10%

Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued

Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70

Full year 2024 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 10%

Medtronic plc Increases Cash Dividend for the First Quarter of Fiscal Year 2025, Payable on July 12, 2024

These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

Medtronic plc Announces its Investigational OmniaSecure Defibrillation Lead Met its Primary Safety and Effectiveness Endpoints, Existing Safety and Effectiveness Endpoints

Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release

Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

Medtronic plc Receives FDA Approval for Inceptiv Closed-Loop Spinal Cord Stimulator

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop